🔍 📞 🔍
Main Menu
Sign into your HANYS account

- Casirivimab/Imdevimab

Sold under the brand name REGEN-COV, is an experimental medicine developed by the American biotechnology company Regeneron Pharmaceuticals. It is an artificial "antibody cocktail" designed to produce resistance against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.